Peter Kirwan

4.4k total citations
34 papers, 434 citations indexed

About

Peter Kirwan is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Peter Kirwan has authored 34 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 20 papers in Epidemiology and 7 papers in Virology. Recurrent topics in Peter Kirwan's work include HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (12 papers) and HIV Research and Treatment (7 papers). Peter Kirwan is often cited by papers focused on HIV/AIDS Research and Interventions (15 papers), HIV, Drug Use, Sexual Risk (12 papers) and HIV Research and Treatment (7 papers). Peter Kirwan collaborates with scholars based in United Kingdom, United States and Netherlands. Peter Kirwan's co-authors include Valérie Delpech, Alison Brown, Dana Ogaz, Sophie Nash, Sara Croxford, N. Connor, Daniela De Angelis, O Nöel Gill, Gwenda Hughes and Martina Furegato and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and AIDS.

In The Last Decade

Peter Kirwan

34 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kirwan United Kingdom 12 312 257 90 76 47 34 434
Roel Achterbergh Netherlands 12 429 1.4× 381 1.5× 178 2.0× 76 1.0× 35 0.7× 18 528
Liza Coyer Netherlands 13 411 1.3× 320 1.2× 171 1.9× 44 0.6× 49 1.0× 41 557
Sharaf Ali Shah Pakistan 15 339 1.1× 388 1.5× 125 1.4× 84 1.1× 13 0.3× 46 613
Vivian Levy United States 12 208 0.7× 261 1.0× 86 1.0× 55 0.7× 84 1.8× 24 441
Pedro Gonzáles United States 13 428 1.4× 319 1.2× 126 1.4× 121 1.6× 15 0.3× 30 532
S Dougan United Kingdom 11 253 0.8× 210 0.8× 119 1.3× 59 0.8× 56 1.2× 19 397
Kyle Bernstein United States 9 293 0.9× 238 0.9× 64 0.7× 64 0.8× 83 1.8× 16 466
Catriona Ooi Australia 11 189 0.6× 243 0.9× 87 1.0× 24 0.3× 73 1.6× 45 395
Caroline Carnevale United States 9 191 0.6× 141 0.5× 48 0.5× 22 0.3× 32 0.7× 31 279
Daisuke Mizushima Japan 14 251 0.8× 183 0.7× 23 0.3× 86 1.1× 54 1.1× 51 461

Countries citing papers authored by Peter Kirwan

Since Specialization
Citations

This map shows the geographic impact of Peter Kirwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kirwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kirwan more than expected).

Fields of papers citing papers by Peter Kirwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kirwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kirwan. The network helps show where Peter Kirwan may publish in the future.

Co-authorship network of co-authors of Peter Kirwan

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kirwan. A scholar is included among the top collaborators of Peter Kirwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kirwan. Peter Kirwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dunn, David, Ellen White, Valérie Delpech, et al.. (2023). Electronic health records to capture primary outcome measures: two case studies in HIV prevention research. Trials. 24(1). 244–244. 2 indexed citations
3.
Kirwan, Peter, Sara Croxford, Adamma Aghaizu, et al.. (2022). Re‐assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing. HIV Medicine. 23(11). 1127–1142. 12 indexed citations
5.
Kirwan, Peter, André Charlett, Paul Birrell, et al.. (2022). Trends in COVID-19 hospital outcomes in England before and after vaccine introduction, a cohort study. Nature Communications. 13(1). 4834–4834. 16 indexed citations
6.
Brown, Alison, Sara Croxford, Sophie Nash, et al.. (2021). COVID‐19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID‐19 pandemic in England. HIV Medicine. 23(1). 90–102. 13 indexed citations
7.
Presanis, Anne M., Ross Harris, Peter Kirwan, et al.. (2021). Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model. The Lancet Public Health. 6(10). e739–e751. 9 indexed citations
8.
Mulchandani, Ranya, Hayley E Jones, A. E. Ades, et al.. (2021). Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workers. Journal of Infection. 82(5). 151–161. 7 indexed citations
9.
Birrell, Paul, Peter Kirwan, Dana Ogaz, et al.. (2021). Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study. The Lancet HIV. 8(7). e440–e448. 13 indexed citations
10.
Dunn, David, Peter Weatherburn, Fiona Lampe, et al.. (2020). Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self‐testing trial. HIV Medicine. 21(9). 588–598. 9 indexed citations
11.
Kirwan, Peter, Matthew Hibbert, Meaghan Kall, et al.. (2020). HIV prevalence and HIV clinical outcomes of transgender and gender‐diverse people in England. HIV Medicine. 22(2). 131–139. 5 indexed citations
12.
Allen, Hester, Peter Kirwan, Alison Brown, et al.. (2020). Does being on HIV antiretroviral therapy increase the risk of syphilis? An analysis of a large national cohort of MSM living with HIV in England 2009–2016. Sexually Transmitted Infections. 97(3). 221–225. 4 indexed citations
13.
Figueroa, José Natal, Laura Waters, Sara Croxford, et al.. (2019). HIV care cost in England: a cross‐sectional analysis of antiretroviral treatment and the impact of generic introduction. HIV Medicine. 20(6). 377–391. 8 indexed citations
14.
Birrell, Paul, Martyn Plummer, Peter Kirwan, et al.. (2019). Extending Bayesian back-calculation to estimate age and time specific HIV incidence. Lifetime Data Analysis. 25(4). 757–780. 4 indexed citations
15.
White, Ellen, David Dunn, Monica Desai, et al.. (2019). Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial. Sexually Transmitted Infections. 95(6). 449–454. 14 indexed citations
16.
Nash, Sophie, N. Connor, Peter Kirwan, et al.. (2018). Towards elimination of HIV transmission, AIDS and HIV‐related deaths in the UK. HIV Medicine. 19(8). 505–512. 48 indexed citations
17.
Croxford, Sara, Zhanxin Yin, Meaghan Kall, et al.. (2018). Where do we diagnose HIV infection? Monitoring new diagnoses made in nontraditional settings in England, Wales and Northern Ireland. HIV Medicine. 19(7). 465–474. 5 indexed citations
18.
Mohan, Keerthi, Matthew Hibbert, Tristan Childs, et al.. (2017). What is the overlap between HIV and shigellosis epidemics in England: further evidence of MSM transmission?. Sexually Transmitted Infections. 94(1). 67–71. 23 indexed citations
19.
Winter, Joanne R., Helen R. Stagg, Colette Smith, et al.. (2017). Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV. AIDS. 31(17). 2403–2413. 6 indexed citations
20.
Simmons, Ruth, Peter Kirwan, Kazim Beebeejaun, et al.. (2015). Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study. BMC Medicine. 13(1). 297–297. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026